Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Global Wilson’s Disease Treatment Market, By Treatment (Medications, others), Distribution Channel (Government, Hospitals, Medical Practitioners), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Sep 2017

Wilson's Disease Treatment Market Wilson’s disease is a genetic disorder caused by the loss of function of the ATP7B copper-binding protein that leads to impaired copper transport and excretion, which r

Coherent Market Insights
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Drugs, Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)) - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : May 2017

Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years

Coherent Market Insights
Global Erectile Dysfunction Market, By Product (Viagra (Sildenafil citrate), Cialis (Tadalafil), Stendra/Spedra, Levitra/Staxyn, Zydena (Udenafil), Vitaros (Alprostadil Cream)), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Apr 2017

Erectile Dysfunction: A Prominent Age Related Disorder Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient

Coherent Market Insights
Global Tuberculosis Drugs Market, By Therapy Type (First Line Drugs Therapy, Second Line Drugs Therapy, Combination Drugs Therapy), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Mar 2017

Tuberculosis Drugs: Hopes Pinned on Renewed Government Investments in Emerging Economies Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked. Thankfully, ext

Coherent Market Insights
Global Prefilled Syringes Market, By Drug Type (Biologics, Vaccines, Insulin), Material (Glass, Plastic & Polymer), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Aug 2017

Prefilled Syringes- Insights into Novel Drug Delivery System The prefilled syringes are one of the fastest growing choices for the unit dose delivery and has emerged as one of the most convenient way of drug

Coherent Market Insights
Global Precision Medicine Market, By Technology (Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular, Diagnostics, Big Data Analytics), Application (Oncology, CNS, Hematology, Respiratory, Immunology), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025

Published Date : Sep 2017

Precision Medicine Market – Not one-size fits all Precision medicine is an emerging field, which tailors the treatment according to the individual’s genetic makeup, lifestyle, and environment. Th

Coherent Market Insights
Global Opioids Agonist Drugs Market, By Product Type (Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone), Therapeutic Application (Pain Management, Cough Treatment, Diarrhea Treatment), and Geography - Trends, Analysis and Forecast till 2024

Published Date : Mar 2017

Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth Opioids are generally prescribed for treating pain. The opioid drug class includes morphine, hydrocodone, oxycodone, heroin, codeine, morphine

Coherent Market Insights
Global Smoking Cessation and Nicotine De-addiction Products Market, By Product Type (Nicotine Replacement Therapy, Drugs, E-Cigarettes), Distribution Channel (Hospital Pharmacies, Online Channel, Retail Pharmacies), Geography - Trends, Analysis, and Forecast till 2024

Published Date : Mar 2017

Are E-cigarettes the E-asy Way Out of Smoking? Cigarette packs have been mandatorily carrying a warning stating ‘Smoking is injurious to Health’, while some countries have resorted to even more gr

Coherent Market Insights
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, Subunit and DNA Vaccines, Conjugated Vaccines), Animal Type (Companion Animal, Livestock Animal), and Geography - Trends, Analysis, and Forecast till 2024

Published Date : Feb 2017

Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccin

Coherent Market Insights
Global Pharmaceutical Excipients Market, By Chemistry (Plants, Animals, Minerals, Synthetic Source), Functionality (Binders, Diluents, Glidents, Disintegrants), Application (Oral, Parenteral, Topical), and Geography - Trends, Analysis and Forecast till 2024

Published Date : Feb 2017

Pharmaceutical Excipients – Paving the way for Low-cost Pharmaceuticals Pharmaceutical excipients are crucial contents of a formulation that enable effective drug absorption. Excipients must suit the in

Coherent Market Insights
Erythromycin Market, by Formulation (Gel, Tablet, Topical Solution, Ointment, and Others), by Disease Indication (Respiratory Tract Infections, Eye Infections, Ear Infections, Skin and Soft Tissue Infection, Gastro-intestinal Infections, and Others) by Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Erythromycin is an antibiotic, which is used to treat certain kind of bacterial infections. Erythromycin topical preparations are largely used on the skin to help control acne. The antibiotic is also used in combination with other medicines and are applied topically o

Coherent Market Insights
Malignant Ascites Treatment Market, by Treatment Type (Therapeutic Treatment and Surgical Treatment), by Application (Ovarian Cancer, Breast Cancer, Gastrointestinal Cancer, Colorectal Cancer, Carcinoma of Unknown Primary, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis 2018-2026

To Be Published : Aug 2018

Ascites is the condition characterized by formation of excessive fluid in the abdominal cavity, particularly in the peritoneal cavity. It causes when the body is unable to eliminate out fluids. When ascites is developed due to cancer, it is called as malignant periton

Coherent Market Insights
Cellulite Treatment Market, by Treatment Procedure (Non-invasive, Minimally-invasive, and Topical Treatment), by Cellulite (Soft Cellulite, Hard Cellulite, and Edematous Cellulite), by End User, and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis 2018-2026

To Be Published : Aug 2018

Cellulite is a condition in which a person’s skin of their thighs, buttocks, and hips appears dimpled. Common names for cellulite include cottage cheese skin, orange-peel skin, hail damage, and the mattress phenomenon. This condition is commonly observed in wome

Coherent Market Insights
Blepharitis Treatment Market, By Disease Type (Posterior Blepharitis, Anterior Blepharitis, and Mixed Blepharitis), By Treatment Type (Antibiotic Therapy (Topical Corticosteroids, Topical Antibodies, and Oral Antibodies), Ointments, Eye Cleansers, and Others), By End User (Hospitals, Specialty Centers, and Others), By Region - Size, Share, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of

Coherent Market Insights
Hunter Syndrome Treatment Market, by Treatment Type (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and Others), by End Users (Hospitals, Clinics, Specialty Care Unit, and Others), and by Geography - Size, Share, Outlook and Opportunity Analysis 2018-2026

To Be Published : Aug 2018

Hunter syndrome also called as Mucopolysaccaridosis type II (MPS II), is the disorder affecting several parts of the body. Hunter syndrome is inherited genetic disorder caused by a malfunctioning or missing enzyme. At birth hunter syndrome individuals do not display a

Coherent Market Insights
Uterine Cancer Drugs Market, by Indication (Endometrial Cancer and Uterine Sarcoma), by Product Type (Megestrol Acetate, Dacarbazine (DTIC), Docetaxel (Taxotere), Gemcitabine (Gemzar), Epirubicin (Ellence), Paclitaxel (Taxol), Temozolomide (Temodar), and Others), by Distribution Channels (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Uterine cancer is one of the most common gynecologic malignancy among female cancer patients. This uterine cancer is of two types: endometrial cancer and uterine sarcoma. Endometrial cancer is caused due to uncontrolled growth of inner linings of uterus. Endometrial c

Coherent Market Insights
Gynecological Cancer Drugs Market, By Therapeutic Modality (Chemotherapy, Targeted Therapy, and Hormonal Therapy), By Indication (Uterine Cancer, Ovarian Cancer, Vaginal & Vulvar Cancer, and Cervical Cancer), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Gynecological cancer is defined as uncontrolled growth and spread of abnormal cells in the female reproductive organs such as cervix, uterus, ovaries, vagina, and vulva. Furthermore, several factors responsible for occurrence of gynecological cancer includes infection

Coherent Market Insights
Chronic Myeloid Leukemia Treatment Market, By Drug Type (Bosulif (Bosutinib), Gleevec (Imatinib), Iclusig (Ponatinib), Sprycel (Dasatinib), Tasigna (Nilotinib), Synribo (Omacetaxine Mepesuccinate), Asciminib, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a blood-cell cancer that begins in the blood-forming cells of the bone marrow. Myeloid cells are a type of immature cells that are capable of making white blood cells and when these ce

Coherent Market Insights
Thyroid Cancer Drugs Market, By Product Type (Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Cometriq (Cabozantinib-S-Malate), Lenvatinib Mesylate, Nivolumab, Vandetanib, and Others), By End Users (Hospitals, Oncology Clinics, Research Organizations, and Others), and By Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

In the recent past, increasing number of thyroid cancers were diagnosed at an early stage of the treatment as several new technologies has arrived with drugs. Advanced treatments resulting into long term survival, minimum complications of surgery and improved quality

Coherent Market Insights
Porphyria Treatment Market, by Drugs (Thorazine, Chlorpromazine, Panhematin and Hemin and Others), by End User (Hospitals, Clinics, and Research Centers) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Porphyria is an inherited rare disorder that affects the nervous system or skin and may cause abdominal pain. Cells of porphyria patients are unable to change body chemicals called porphyrins and its precursors into heme, the substance responsible for blood color. Acc

Coherent Market Insights
Antiepileptic Drugs Market, by Drug Class (First Generation, Second Generation, and Third Generation), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. Epilepsy is categorized into generalized seizures and partial seizures based on the areas affected in the brain. Generalized seizures affect the wh

Coherent Market Insights
Drug Screening Market, by Product Type (Instruments (Immunoassay analyzers, Chromatography Instruments, Breathalyzers, Drug testing Cups, Dip Cards, and Oral Fluid Testing Products) and Consumables), by Application (Urine Testing, Breath Testing, Oral Fluid Testing, Hair Testing, and Others), by End User, and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Drug screening involves testing of the samples such as urine, breath, oral fluid, hair, and others for presence of any substances over the limit. The significance of the drug screening is that a person under influence of the drugs or alcohol is liable for road acciden

Coherent Market Insights
Bioresorbable Polymers Market, by Polymer Type (Agro-polymers and Biopolysters), by Application (Drug Delivery, Orthopedics, and Others), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Bioresorbable polymers, also known as degradable polymers, are commonly used in various biomedical applications such as suturing thread, arterial stents, intravenous drug-delivery devices, vascular grafts, temporary bone fixation devices, and degradable sutures. These

Coherent Market Insights
Fibromyalgia Treatment Market, by Drug Type (Antidepressants, Anticonvulsants, Muscle Relaxants, Analgesics and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is stil

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.